News | May 17, 2023
Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification, selection and transition to the new leadership takes place in the company.
The consideration for the medicines in India is valued at Rs 180.48 crore
Adjusted PAT declined 18.8% YoY
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)